BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 36542978)

  • 21. Cascade-Enhanced Catalytic Nanocomposite with Glutathione Depletion and Respiration Inhibition for Effective Starving-Chemodynamic Therapy Against Hypoxic Tumor.
    Zhang Y; Hu H; Deng X; Song Q; Xing X; Liu W; Zhang Y
    Int J Nanomedicine; 2022; 17():5491-5510. PubMed ID: 36438608
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer cell membrane-coated C-TiO
    Ning S; Dai X; Tang W; Guo Q; Lyu M; Zhu D; Zhang W; Qian H; Yao X; Wang X
    Acta Biomater; 2022 Oct; 152():562-574. PubMed ID: 36067874
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fusiform-Like Copper(II)-Based Metal-Organic Framework through Relief Hypoxia and GSH-Depletion Co-Enhanced Starvation and Chemodynamic Synergetic Cancer Therapy.
    Wang Z; Liu B; Sun Q; Dong S; Kuang Y; Dong Y; He F; Gai S; Yang P
    ACS Appl Mater Interfaces; 2020 Apr; 12(15):17254-17267. PubMed ID: 32227859
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biodegradable BiOCl platform for oxidative stress injury-enhanced chemodynamic/radiation therapy of hypoxic tumors.
    Liu Y; Zhang J; Du J; Song K; Liu J; Wang X; Li B; Ouyang R; Miao Y; Sun Y; Li Y
    Acta Biomater; 2021 Jul; 129():280-292. PubMed ID: 34033970
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Silk fibroin-capped metal-organic framework for tumor-specific redox dyshomeostasis treatment synergized by deoxygenation-driven chemotherapy.
    Yu H; Li Y; Zhang Z; Ren J; Zhang L; Xu Z; Kang Y; Xue P
    Acta Biomater; 2022 Jan; 138():545-560. PubMed ID: 34775125
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyaluronan-fullerene/AIEgen nanogel as CD44-targeted delivery of tirapazamine for synergistic photodynamic-hypoxia activated therapy.
    Hong X; Xu X; Liu Z; Liu S; Yu J; Wu M; Ma Y; Shuai Q
    Nanotechnology; 2021 Aug; 32(46):. PubMed ID: 34325415
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclic reactions-mediated self-supply of H
    Zhang X; He C; Chen Y; Chen C; Yan R; Fan T; Gai Y; Yang T; Lu Y; Xiang G
    Biomaterials; 2021 Aug; 275():120987. PubMed ID: 34175561
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cancer-Selective Bioreductive Chemotherapy Mediated by Dual Hypoxia-Responsive Nanomedicine upon Photodynamic Therapy-Induced Hypoxia Aggravation.
    Zhu R; He H; Liu Y; Cao D; Yan J; Duan S; Chen Y; Yin L
    Biomacromolecules; 2019 Jul; 20(7):2649-2656. PubMed ID: 31125209
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tirapazamine-loaded CalliSpheres microspheres enhance synergy between tirapazamine and embolization against liver cancer in an animal model.
    Li Q; Liu Y; Guo X; Zhang L; Li L; Zhao D; Zhang X; Hong W; Zheng C; Liang B
    Biomed Pharmacother; 2022 Jul; 151():113123. PubMed ID: 35594702
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multifunctional Theranostic Liposomes Loaded with a Hypoxia-Activated Prodrug for Cascade-Activated Tumor Selective Combination Therapy.
    Dai Y; Wang B; Sun Z; Cheng J; Zhao H; Wu K; Sun P; Shen Q; Li M; Fan Q
    ACS Appl Mater Interfaces; 2019 Oct; 11(43):39410-39423. PubMed ID: 31578854
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nitric oxide-mediated regulation of mitochondrial protective autophagy for enhanced chemodynamic therapy based on mesoporous Mo-doped Cu
    Zhou Z; Gao Z; Chen W; Wang X; Chen Z; Zheng Z; Chen Q; Tan M; Liu D; Zhang Y; Hou Z
    Acta Biomater; 2022 Oct; 151():600-612. PubMed ID: 35953045
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nanocatalytic Theranostics with Glutathione Depletion and Enhanced Reactive Oxygen Species Generation for Efficient Cancer Therapy.
    Fu LH; Wan Y; Qi C; He J; Li C; Yang C; Xu H; Lin J; Huang P
    Adv Mater; 2021 Feb; 33(7):e2006892. PubMed ID: 33394515
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Janus Gold Triangle-Mesoporous Silica Nanoplatforms for Hypoxia-Activated Radio-Chemo-Photothermal Therapy of Liver Cancer.
    Wang Z; Chang ZM; Shao D; Zhang F; Chen F; Li L; Ge MF; Hu R; Zheng X; Wang Y; Dong WF
    ACS Appl Mater Interfaces; 2019 Sep; 11(38):34755-34765. PubMed ID: 31474108
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Organosilica-Based Hollow Mesoporous Bilirubin Nanoparticles for Antioxidation-Activated Self-Protection and Tumor-Specific Deoxygenation-Driven Synergistic Therapy.
    Shan L; Fan W; Wang W; Tang W; Yang Z; Wang Z; Liu Y; Shen Z; Dai Y; Cheng S; Jacobson O; Zhai K; Hu J; Ma Y; Kiesewetter DO; Gao G; Chen X
    ACS Nano; 2019 Aug; 13(8):8903-8916. PubMed ID: 31374171
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oxygen-Independent Synchronized ROS Generation and Hypoxia Prodrug Activation with Z-Scheme Heterostructure Sonosensitizer.
    Chen Y; Zou T; Xin G; Liu X; Yang Y; Wei L; Zhang B; Yu P; Ren Y; Feng Y; Chen R; Cao F; Chen X; Cheng Y
    Adv Mater; 2024 Jan; 36(3):e2307929. PubMed ID: 37856705
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A dual-response drug delivery system with X-ray and ROS to boost the anti-tumor efficiency of TPZ
    Han P; Zhang L; Fu Y; Fu Y; Huang J; He J; Ni P; Khan T; Jiao Y; Yang Z; Zhou R
    Nanoscale; 2022 Dec; 15(1):237-247. PubMed ID: 36472214
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intelligent Nanoplatform with Multi Therapeutic Modalities for Synergistic Cancer Therapy.
    Shao L; Hu T; Fan X; Wu X; Zhou F; Chen B; Tan S; Xu H; Pan A; Liang S; He Y
    ACS Appl Mater Interfaces; 2022 Mar; 14(11):13122-13135. PubMed ID: 35286061
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Glucose/Oxygen-Exhausting Nanoreactor for Starvation- and Hypoxia-Activated Sustainable and Cascade Chemo-Chemodynamic Therapy.
    Guo Y; Jia HR; Zhang X; Zhang X; Sun Q; Wang SZ; Zhao J; Wu FG
    Small; 2020 Aug; 16(31):e2000897. PubMed ID: 32537936
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biomimetic Decoy Inhibits Tumor Growth and Lung Metastasis by Reversing the Drawbacks of Sonodynamic Therapy.
    Zhao H; Zhao B; Li L; Ding K; Xiao H; Zheng C; Sun L; Zhang Z; Wang L
    Adv Healthc Mater; 2020 Jan; 9(1):e1901335. PubMed ID: 31762228
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An efficient delivery of photosensitizers and hypoxic prodrugs for a tumor combination therapy by membrane camouflage nanoparticles.
    Wang H; Zhang C; Zhang Y; Tian R; Cheng G; Pan H; Cui M; Chang J
    J Mater Chem B; 2020 Apr; 8(14):2876-2886. PubMed ID: 32191252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.